Potential thyroliberin affinity labels II: Chloroacetyl substituted phenylalanyl prolineamides

Area of Science:

• Medicinal Chemistry
• Endocrinology
• Pharmacology

Background:

• Thyroliberin (TRH) is a hypothalamic hormone regulating thyroid-stimulating hormone (TSH) release.
• TRH analogs are investigated for therapeutic potential and understanding receptor interactions.
• Developing specific TRH antagonists is a key research objective.

Purpose of the Study:

• To synthesize and evaluate novel thyroliberin (TRH) analogs as potential TRH antagonists.
• To investigate the agonist and antagonist activities of these synthesized compounds.
• To explore the structure-activity relationship of TRH analogs.

Main Methods:

• Synthesis of three specific TRH analogs: N-m-chloroacetylbenzoyl-phenylalanyl-prolineamide (VIa), N-p-chloroacetylbenzoyl-phenylalanyl-prolineamide (VIb), and N-chloroacetyl-alanyl-phenylalanyl-prolineamide (IX).
• Preparation of cyclo(Phe-Pro) as an analog of the TRH metabolite cyclo(His-Pro).
• Pharmacological evaluation of synthesized compounds for TRH antagonist and agonist activities.

Main Results:

• Compounds VIa, VIb, and IX did not exhibit significant TRH antagonist activity.
• Compounds VIa and IX displayed weak TRH agonist activity.
• Cyclo(Phe-Pro) demonstrated significant TRH antagonist activity but no agonist activity.

Conclusions:

• The designed TRH analogs (VIa, VIb, IX) were ineffective as TRH antagonists.
• Cyclo(Phe-Pro) represents a promising TRH antagonist with potential therapeutic applications.
• Further research into cyclo(Phe-Pro) analogs may yield potent TRH receptor modulators.